RASA2 and cancer: Expression of the RAS-GTPase activating protein (GAP) protein NF1 is associated with activity of the RAS/MAPK pathway, and mutations in or deletions of the NF1 gene have been found in a number of cancers, including neuroblastoma [29, 42].